46-60 of 344
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
MinuteCE®Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
MinuteCE®Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
MinuteCE®All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CEImproving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CERedefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
- advertisement
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
CME/CEDecision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Barbara O'Brien, MD
Barbara O'Brien, MD
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Nadia Harbeck, MD, PhD
Case Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
CME/CECase Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
Brain Metastases Management: From Detection to Multidisciplinary Care
MinuteCE®Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
MinuteCE®HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Barbara O'Brien, MD
Nadia Harbeck, MD, PhD
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
MinuteCE®First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Barbara O'Brien, MD
Nadia Harbeck, MD, PhD
- advertisement
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
MinuteCE®Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
Benjamin Levy, MD
Melin Khandekar, MD, PhD
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Managing Brain Metastases Through Multidisciplinary Team Collaboration
MinuteCE®Managing Brain Metastases Through Multidisciplinary Team Collaboration
Benjamin Levy, MD
